These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 21086219

  • 1. A practical guide to pediatric multiple sclerosis.
    Huppke P, Gärtner J.
    Neuropediatrics; 2010 Aug; 41(4):157-62. PubMed ID: 21086219
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Advances in the treatment of multiple sclerosis?].
    Tackenberg B, Himmerich H, Wellek A, Oertel WH, Sommer N.
    MMW Fortschr Med; 2007 May 21; 149 Suppl 2():51-5. PubMed ID: 17724968
    [Abstract] [Full Text] [Related]

  • 5. [Diagnostics and drug therapy of multiple sclerosis].
    Suomen Neurologinen Yhdistys ry.
    Duodecim; 2002 May 21; 118(13):1411-23. PubMed ID: 12239889
    [No Abstract] [Full Text] [Related]

  • 6. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P.
    Expert Rev Neurother; 2004 May 21; 4(3):455-63. PubMed ID: 15853542
    [Abstract] [Full Text] [Related]

  • 7. [Therapy of multiple sclerosis].
    Simó M.
    Neuropsychopharmacol Hung; 2009 Mar 21; 11(1):23-6. PubMed ID: 19731815
    [Abstract] [Full Text] [Related]

  • 8. The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews.
    Clerico M, Rivoiro C, Contessa G, Viglietti D, Durelli L.
    Clin Neurol Neurosurg; 2008 Nov 21; 110(9):878-85. PubMed ID: 18164542
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Current therapeutic recommendations in multiple sclerosis.
    Berger T.
    J Neurol Sci; 2009 Dec 21; 287 Suppl 1():S37-45. PubMed ID: 20106347
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacologic management of multiple sclerosis.
    Blasier MG.
    Urol Nurs; 2008 Jun 21; 28(3):217-9. PubMed ID: 18605517
    [No Abstract] [Full Text] [Related]

  • 15. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
    Tedeholm H, Skoog B, Hillert J, Runmarker B, Stawiarz L, Oluf A.
    Lakartidningen; 2008 Jun 21; 104(22):1684-8. PubMed ID: 17601317
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of pediatric multiple sclerosis and variants.
    Pohl D, Waubant E, Banwell B, Chabas D, Chitnis T, Weinstock-Guttman B, Tenembaum S, International Pediatric MS Study Group.
    Neurology; 2007 Apr 17; 68(16 Suppl 2):S54-65. PubMed ID: 17438239
    [Abstract] [Full Text] [Related]

  • 17. Glatiramer and suspected multiple sclerosis. No proven advantage.
    Prescrire Int; 2010 Aug 17; 19(108):160. PubMed ID: 20941852
    [No Abstract] [Full Text] [Related]

  • 18. Optic neuritis and risk of MS: differential diagnosis and management.
    Osborne BJ, Volpe NJ.
    Cleve Clin J Med; 2009 Mar 17; 76(3):181-90. PubMed ID: 19258465
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.